Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ghezzi

Showing results (11-20 of 198) with videos related to

Pageof 20
Sort By:
Neuroimmunomodulation|February 16, 2002
Tumor necrosis factor and motoneuronal degeneration: an open problemP Ghezzi, T Mennini
Cell Death and Differentiation|July 10, 2004
Erythropoietin as an antiapoptotic, tissue-protective cytokineP Ghezzi, M Brines
European Journal of Cancer & Clinical Oncology|December 1, 1988
Depression of liver drug metabolism in sarcoma-bearing mice. Evidence for a circulating factor and dissociation from lipolytic activityR Bertini, P Ghezzi
Lymphokine Research|January 1, 1988
Dexamethasone modulation of LPS, IL-1, and TNF stimulated serum amyloid A synthesis in miceP Ghezzi, J D Sipe
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Protection against pulmonary oxygen toxicity by interleukin-1 and tumor necrosis factor: role of antioxidant enzymes and effect of cyclooxygenase inhibitorsC W White, P Ghezzi
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1988
IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gammaP Ghezzi, C A Dinarello
Biochemical and Biophysical Research Communications|April 14, 1986
Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in miceP Ghezzi, B Saccardo, M Bianchi
Neuroimmunomodulation|January 1, 1995
Proinflammatory cytokines as pathogenetic mediators in the central nervous system: brain-periphery connectionsR Faggioni, F Benigni, P Ghezzi
Immunopharmacology|December 1, 1986
Role of reactive oxygen intermediates in the hepatotoxicity of endotoxinP Ghezzi, B Saccardo, M Bianchi
Minerva Medica|May 9, 1977
[Conductivity of the dialysis bath. Measurement, significance and electrolyte and clinical correlations]P Ghezzi, G Frigato, R Palanca
Pageof 20

Showing results (11-20 of 198) with videos related to

Sort By:
Pageof 20
Neuroimmunomodulation|February 16, 2002
Tumor necrosis factor and motoneuronal degeneration: an open problemP Ghezzi, T Mennini
Cell Death and Differentiation|July 10, 2004
Erythropoietin as an antiapoptotic, tissue-protective cytokineP Ghezzi, M Brines
European Journal of Cancer & Clinical Oncology|December 1, 1988
Depression of liver drug metabolism in sarcoma-bearing mice. Evidence for a circulating factor and dissociation from lipolytic activityR Bertini, P Ghezzi
Lymphokine Research|January 1, 1988
Dexamethasone modulation of LPS, IL-1, and TNF stimulated serum amyloid A synthesis in miceP Ghezzi, J D Sipe
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Protection against pulmonary oxygen toxicity by interleukin-1 and tumor necrosis factor: role of antioxidant enzymes and effect of cyclooxygenase inhibitorsC W White, P Ghezzi
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1988
IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gammaP Ghezzi, C A Dinarello
Biochemical and Biophysical Research Communications|April 14, 1986
Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in miceP Ghezzi, B Saccardo, M Bianchi
Neuroimmunomodulation|January 1, 1995
Proinflammatory cytokines as pathogenetic mediators in the central nervous system: brain-periphery connectionsR Faggioni, F Benigni, P Ghezzi
Immunopharmacology|December 1, 1986
Role of reactive oxygen intermediates in the hepatotoxicity of endotoxinP Ghezzi, B Saccardo, M Bianchi
Minerva Medica|May 9, 1977
[Conductivity of the dialysis bath. Measurement, significance and electrolyte and clinical correlations]P Ghezzi, G Frigato, R Palanca
Pageof 20